Related Experiment Video
Updated: May 6, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Guideline bone disease
1Division of Nephrology and Hypertension, Beth Israel Medical Center, New York, N.Y., USA.
Insights
Current dialysis guidelines for bone and mineral targets are flawed. They use an outdated parathyroid hormone (PTH) assay, potentially leading to adverse patient outcomes like adynamic bone disease.
Area of Science:
- Nephrology
- Mineral Metabolism
- Bone Biology
Background:
- Dialysis units exhibit poor compliance with KDOQI and KDIGO bone and mineral guideline targets.
- Current guidelines rely heavily on observational data and an obsolete parathyroid hormone (PTH) assay.
Purpose of the Study:
- To critique the current KDOQI and KDIGO guideline targets for bone and mineral management in dialysis patients.
- To highlight the limitations of the intact PTH assay in assessing bone turnover and guiding treatment.
Main Methods:
- Analysis of existing literature and guideline recommendations.
- Critique of the biochemical assays used for PTH measurement.
Main Results:
- The intact PTH assay inaccurately measures biologically active PTH (1-84 PTH) and its antagonist (7-84 PTH).
- The assay cannot reliably differentiate between high and low bone turnover states within guideline target ranges.
- Adherence to current targets is associated with increased adynamic bone disease, elevated calcium and phosphorus levels, and potentially worse patient outcomes.
Conclusions:
- The current KDOQI and KDIGO bone and mineral guidelines require revision due to reliance on obsolete assays and observational data.
- The limitations of the intact PTH assay may lead to suboptimal treatment strategies and adverse effects in dialysis patients.
- Future guidelines should incorporate more accurate PTH assays and consider the biological activity of different PTH fragments.
Abstract:
In the current issue of Blood Purification, Palomares et al. [Blood Purif 2013;36:122-131] bemoan the poor level of compliance in dialysis units in achieving compliance with KDOQI and KDIGO bone and mineral guideline targets. These targets are based almost completely on observational data and rely on an obsolete assay for PTH. The so-called intact PTH assay measures both 1-84 PTH and 7-84 PTH; the latter has been demonstrated to possess biological activity that is antagonistic to that of 1-84 PTH. The assay cannot reliably distinguish high from low bone turnover in the target ranges suggested by the guideline panels. Targeting these ranges leads to an increased incidence of adynamic bone disease, higher calcium and phosphorus, and likely poor patient outcomes.
More Related Videos
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Classification of Bones
Long and Short Bones
The appendicular skeleton, particularly the upper and lower limbs, is primarily made of long and short bones. The...
Bone as Supporting Connective Tissue
Bone Matrix
Bone, or osseous tissue, is a connective tissue that has a large amount of two different types of matrix material. The organic matrix is similar to the matrix material found in other connective tissues, including some amount of collagen and elastic fibers. This gives strength and flexibility to the tissue. The inorganic matrix consists of mineral salts— mostly calcium salts—...
Bone Structure
Osteoclasts in Bone Remodeling

